# NA-Selank

> NA-Selank (N-Acetyl Selank) is a modified version of Selank in which an acetyl group has been added to improve resistance to enzymatic breakdown and extend its duration of activity. It is positioned in research and vendor literature as a longer-acting alternative to standard Selank, intended to produce similar anxiolytic and mild nootropic effects with less frequent dosing. Independent published research specifically on the N-acetylated form is considerably more limited than for Selank itself, so much of its proposed profile is extrapolated from the parent compound. It is not approved for medical use and is available only as a research compound.

- URL: https://www.lifeconverted.com/peptides/na-selank
- Also known as: N-Acetyl Selank
- Primary category: Cognitive & Neuro
- Effectiveness rank: #9 in Cognitive & Neuro
- Evidence level: Moderate evidence
- Route: Subcutaneous (Historically discussed as an extended-duration analog of an intranasally-used parent compound; this profile reflects subcutaneous injection as used in current research contexts.)
- Dose range: 250-750 mcg
- Dose tiers: low 250 mcg; moderate 500 mcg; high 750 mcg
- Half-life: Reported to be longer than standard Selank due to the acetyl modification, though precise human pharmacokinetic values have not been well characterized.
- Timing: Morning
- Cycle: 4-6 weeks on, 2-4 weeks off (Cycling recommendations are extrapolated from parent-compound research rather than dedicated studies.)
- Storage: Store lyophilized peptide refrigerated (2-8°C) or frozen prior to reconstitution, protected from light. After reconstitution, keep refrigerated and use within about 2-4 weeks.

## Mechanism of action

NA-Selank is proposed to act through the same general pathways attributed to Selank, including modulation of GABAergic and serotonergic signaling and effects on BDNF expression, with the acetyl modification intended to slow enzymatic degradation and prolong systemic exposure. Direct human pharmacokinetic comparisons between Selank and NA-Selank are limited.

## Reported benefits

- Proposed longer duration of action compared with standard Selank
- Explored for anxiolytic effects without apparent sedation
- Studied to a limited extent for mild nootropic and stress-modulating effects
- May allow less frequent dosing than the parent peptide

## Reported side effects

- Injection site irritation
- Mild headache reported anecdotally
- Limited independent safety data specific to the acetylated form
- Uncertain long-term effects given sparse research

## Common protocols

- Less frequent dosing schedules than standard Selank, based on its proposed extended half-life

## Stacking notes

Sometimes discussed as a substitute for standard Selank in combination protocols with other cognitive-focused peptides; no controlled data exist.

---

Educational information only, not medical advice. Full disclaimer: https://www.lifeconverted.com/disclaimer